EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/24/2025
Back to search
Official data from USPTO
XINSITOL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 35
Filing date
05/30/2023
Registration date
11/26/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CN
Examiner
GULIANO, ROBERT N
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Representatives
Scot A. Duvall STITES & HARBISON PLLC
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for medical purposespharmaceutical preparations for the treatment of kidney disease; Drugs for medical purposespharmaceutical preparations for the treatment of cancer; Drugs for medical purposespharmaceutical preparations for the prevention and treatment of respiratory system disorders; Drugs for medical purposespharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Drugs for medical purposespharmaceutical preparations for the prevention and treatment of infectious diseasespaincancer and tumors; Biological preparations for medical purposesbiological reagents for medical purposes; Biological preparations for medical purposesbiological preparations for the treatment of cancer; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of infectious diseasespaincancer and tumors; Vaccines; Antiallergic medicines for human purposes; Medicines for human purposespharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of infectious diseasespaincancer and tumors; Diagnostic preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Protein supplements for animals; Absorbent wadding for medical purposes
Class 35
Retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; Wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; Marketing services; Commercial administration of the licensing of the goods and services of others; Presentation of goods on communication mediafor retail purposesproviding television home shopping services in the field of general consumer merchandise; Advertising services
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/24/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/24/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/24/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/24/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/22/2025
FIMP
FINAL DISPOSITION PROCESSED
04/22/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/26/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/04/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/21/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2024
RFNT
REFUSAL PROCESSED BY IB
04/16/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/26/2024
RFRR
REFUSAL PROCESSED BY MPU
03/25/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2024
CNRT
NON-FINAL ACTION WRITTEN
03/04/2024
DOCK
ASSIGNED TO EXAMINER
02/22/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/22/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/20/2023
Continuous trademark protection
Get notified about every new filing that threatens XINSITOL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.